Genomic profile helps to predict the clonal evolution and outcome of BCR-ABL-negative myeloproliferative neoplasms by Xiaodong Guo, Wenbo Jia, Xinyu Yang, Hexiao Jia, Hanyang Wu, Yihong Wei, Can Can, Na He, Hailei Zhang, Wancheng Liu, Shuang Yu, Daoxin Ma

Subjects: Get full text

Successful treatment of recalcitrant follicular lichen planus (lichen planopilaris) with the topical JAK 1/2 inhibitor ruxolitinib by Tanja Fetter, Dagmar Wilsmann‐Theis, Luka deVos‐Hillebrand, Natalija Novak, Joerg Wenzel

Subjects: Get full text

Case report: Nephrotic syndrome and portal hypertensive ascites after allogeneic hematopoietic stem cell transplantation: a rare manifestation of chronic graft-versus-host disease by SanXi Ai, YuBing Wen, XiaoHong Fan, TianRui Hua, Wei Ye, XueMei Li, Yan Qin

Subjects: Get full text

Myelofibrosis: Treatment Options After Ruxolitinib Failure by Ruth Stuckey, Adrián Segura Díaz, María Teresa Gómez-Casares

Subjects: Get full text

How we treat polycythemia vera by V. A. Shuvaev, I. S. Martynkevich

Subjects: Get full text

Efficacy and safety of ruxolitinib combined with steroids for first-line treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: a single-center... by Yan Yang, Yuan Huo, Dong Zhou, Zhijie Kang, Yanan Huang, Ying Wang, Guangjun Fan, Liyuan Ma, Jinsong Yan, Jinsong Yan, Jinsong Yan

Subjects: Get full text

Ruxolitinib Delays Nucleus Pulposus Cell Senescence in Rat Intervertebral Discs by Honggang Hao, Weidong Liang, Shuwen Zhang, Xiaoyu Cai, Abulizi Yakefu, Shutao Gao, Chuanhui Xun, Tao Xu, Rui Cao, Weibin Sheng

Subjects: Get full text

Leukocytoclastic vasculitis in JAK2-positive essential thrombocythemia: a case of cytokine-driven urticarial rash responsive to ruxolitinib by Murad Aldarayseh, Leonardo Marmolejos, Dalia Al Zoubi, Michelle Cholankeril

Subjects: Get full text

Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis by Stine Ulrik Mikkelsen, Lasse Kjær, Mads Emil Bjørn, Trine Alma Knudsen, Anders Lindholm Sørensen, Christen Bertel Lykkegaard Andersen, Ole Weis Bjerrum, Nana Brochmann, Daniel El Fassi, Torben A. Kruse, Thomas Stauffer Larsen, Hans Torben Mourits‐Andersen, Claus Henrik Nielsen, Niels Pallisgaard, Mads Thomassen, Vibe Skov, Hans Carl Hasselbalch

Subjects: Get full text

Targeting the IL-15/CD122 signaling pathway: reversing TRM cell-mediated immune memory in vitiligo by Xiangxi Su, Fang Liu

Subjects: Get full text

Successful Treatment of Refractory Graft-Versus-Host Disease with Ruxolitinib in a Child after Autologous Stem Cell Transplantation by Nurşah Eker, Burcu Tufan Taş, Ömer Doğru, Emel Şenay, Ayşe Gülnur Tokuç, Ahmet Koç

Subjects: Get full text

Jak inhibitors in the treatment of alopecia areata - a literature review by Paulina Krzeszowska, Aleksandra Kujawa, Karolina Krochmal, Wojciech Pisarek, Adrianna Samoraj, Jakub Zajączkowski, Kacper Stępniak, Jan Wilk, Karolina Marrodán-Wojtczak, Radosław Kuźma

Subjects: Get full text

Case report: Successful use of ruxolitinib to treat interstitial pneumonia as an unusual primary presentation in primary myelofibrosis—two birds with one stone by Pingping Xiao, Zhigao Dong, Qingqing Wang, Junnan Su, Yongquan Chen, Yiwan Lin

Subjects: Get full text

Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023 by Saleh F. Alqifari, Musaab Habibulla Gari, Jeff J. Guo, Shoroq Alamin, Aya K. Esmail, Abdullah K. Esmail, Heba R. Hamad, Ahmed Aljabri, Amirah M. Alatawi, Laila A. Albishi, Mohammed Olaythah Alraddadi, Helal F. Hetta

Subjects: Get full text

Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report by Camille M. Powers, Hannah Verma, Jeremy Orloff, Austin J. Piontkowski, Amy Tiersten, Angela Lamb, Nicholas Gulati

Subjects: Get full text

Long-term follow-up results of ruxolitinib as salvage therapy for chronic graft-versus-host disease by Neslihan Mandaci Sanli, Esen Karakuş

Subjects: Get full text

Primary myelofibrosis: own experience and news from diagnostic and treatment by K. M. Abdulkadyrov, V. A. Shuvaev, I. S. Martynkevich

Subjects: Get full text

Ruxolitinib and oHSV combination therapy increases CD4 T cell activity and germinal center B cell populations in murine sarcoma by Ravi Dhital, Yeaseul Kim, Doyeon Kim, Ilse Hernandez-Aguirre, Jack Hedberg, Alexia Martin, Kevin A. Cassady

Subjects: Get full text

Response to two Janus kinase inhibitors in a boy with SAVI during 2-year follow-up: case report and literature review by Yiting Chen, Yiting Chen, Wenhe Zang, Haoyuan Zhong, Xianqin Deng, Wenting Zhong, Wenting Zhong, Lianyu Wang, Lianyu Wang, Xinying Chen, Xinying Chen, Xinying Chen

Subjects: Get full text

Ruxolitinib in adult dermatomyositis with anti-TIF1γ antibody: a case report and literature review by Xu Jing, Wang Min, Liu Xia, Li Shanshan

Subjects: “…ruxolitinib…”
Get full text